Gary Lask is a Dermatology physician affiliated with University of California, Los Angeles. OpenAlex indexes 114 publications with 3,640 citations (h-index 34).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Medical Plaza
#450
Los Angeles, CA 900953075
Telephone
310-825-0631Registry record last updated 1 Apr 2011.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Solta Medical, a division of Bausch Health US, LLCProgram year20251 payment
- REVANCE THERAPEUTICS, INC.Program year20251 payment
- MIMEDX Group, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
32.3%Corticosteroid32.3%Triamcinolone Acetonide100%Part D≥35 patientsAnti-infectives
30.4%Tetracycline-class Drug12%Doxycycline Monohydrate100%Part D≥17 patientsAzole Antifungal9.5%Ketoconazole100%Part D<11 patients+ 1 more class in this area
Sensory organs
25.9%Corticosteroid25.9%Hydrocortisone63%Clobetasol Propionate37%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Sonic Hedgehog Pathway Inhibition in the Treatment of Advanced Basal Cell Carcinoma
Current Treatment Options in Oncology
2019 - Overview of Kybella (Deoxycholic Acid Injection) as a Fat Resorption Product for Submental Fat
Facial Plastic Surgery
2019 - A novel non-invasive radiofrequency dermal heating device for skin tightening of the face and neck
Journal of Cosmetic and Laser Therapy
2015 - Fractional treatment of aging skin with Tixel, a clinical and histological evaluation
Journal of Cosmetic and Laser Therapy
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Dennis Slamon, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
Robert Modlin, MD
University of California, Los Angeles
Zev Wainberg, MD
University of California, Los Angeles
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”